111, Inc. (YI) Stock Price, Financials & Summary

Price chart

Aug 19Aug 24Aug 27Sep 1Sep 4Sep 10Sep 15Sep 18

Key dataSep 18, 2026

Open$3.55

From 52W high−57.04%

Volume12993.00

Market cap$31.67M

P/E (TTM)—

P/S (TTM)0.0x

Div yield—

Key dataSep 18, 2026

Open

$3.55

From 52W high

−57.04%

Volume

12993.00

Market cap

$31.67M

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

−8.3x

P/E (TTM)

—

RSI (14)

51.2

MomentumView details →

1D Return

+1.69%

YTD Return

+39.84%

SummaryUpdated Jun 1, 2026

111, Inc. (NASDAQ:YI) is a Chinese healthcare technology company that operates an integrated online and offline platform connecting pharmaceutical companies, pharmacies, and consumers. Founded in 2010 and headquartered in Shanghai, the company went public on NASDAQ in September 2018. Originally known as New Peak Group, the company rebranded to 111, Inc. in April 2018. The company has evolved from a traditional pharmaceutical distributor to a digitally-driven healthcare platform that leverages artificial intelligence and data analytics to optimize the pharmaceutical supply chain in China.

Ask drillr about 111, Inc. →

ValuationView details →

P/E (Fwd)

—

P/E (TTM)

—

EV/EBITDA

−8.3x

EV/Sales

0.0x

P/S (TTM)

0.0x

P/B (TTM)

−1.9x

ProfitabilityView details →

Gross Margin

5.73%

Net Margin

−0.91%

EBITDA Margin

−0.39%

ROE (TTM)

83.06%

ROA (TTM)

−5.31%

Asset Turnover

10.09x

GrowthView details →

Revenue YoY

−26.37%

EPS YoY

−39.25%

FCF YoY

+17.86%

Revenue CAGR 3Y

−3.32%

EPS CAGR 3Y

+1.33%

EBITDA YoY

—

MomentumView details →

1D Return

+1.69%

YTD Return

+39.84%

1Y Return

−31.42%

RSI (14)

51.2

vs 50D SMA

−2.26%

vs 200D SMA

−29.75%

Capital & dividendView details →

Debt/Equity

−0.36x

Current Ratio

1.07x

Quick Ratio

0.99x

Div Yield

—

Div Rate

—

Div Growth 1Y

—

EarningsView details →

EPS (Actual)

−$0.60

EPS Surprise

—

Beats (12Q)

—

Next Q EPS Est

—

Avg Surprise (4Q)

—

Rev Surprise

—

Financials snapshotView financials →

Revenue (TTM)

10.44B

Net Income (TTM)

−95.03M

Op. CF (TTM)

—

Next earningsNov 26, 2026 →

Latest newsMore news →

111 Inc. received an unsolicited preliminary non-binding proposal dated September 16, 2026 from Dr. Gang Yu, its co-founder and co-chairman, and another party to acquire the company.3d ago

111, Inc. reported its unaudited financial results for the second quarter ended June 30, 2026, with net revenue of promotional products up 121% and gross profit up 120% year-over-year.3d ago

Similar companies

LifeMD, Inc.LFMDP Sanai Health Industry Group Company Limited01889.HK PetMed Express, Inc.PETS Kyntra Bio, Inc.KYNB Pa Shun International Holdings Limited00574.HK AIxCrypto Holdings, Inc.AIXC Find similar companies →

Latest newsMore news →

111 Inc. received an unsolicited preliminary non-binding proposal dated September 16, 2026 from Dr. Gang Yu, its co-founder and co-chairman, and another party to acquire the company.3d ago 111, Inc. reported its unaudited financial results for the second quarter ended June 30, 2026, with net revenue of promotional products up 121% and gross profit up 120% year-over-year.3d ago